Paid Clinical Trials in Doral, FL
As of August 2026, 87 paid clinical trials are recruiting in Doral, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Doral offers studies at sites including UM Sylvester Comprehensive Cancer Center at Doral for conditions such as Psychosis Associated With Alzheimer's Disease, Anatomic Stage IV Breast Cancer AJCC v8, Atopic Dermatitis, Bipolar I Disorder. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Doral
Trials by drug in Doral
Filter results
Newly added in Doral
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
81 clinical trials
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Shield Post-Approval Study Protocol
ACP-204 in Adults With Alzheimer's Disease Psychosis
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Study of DISC-0974-201 in Participants With IBD and Anemia
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Top Research Study Locations in Doral
Researchers run research studies in Doral, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UM Sylvester Comprehensive Cancer Center at Doral | Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | 18 |
| Dolphin Medical Research | Efficacy, Anemia, Chronic Spontaneous Urticaria | 5 |
| Universal Axon Clinical Research | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypercholesterolaemia | 5 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive, Irritable Bowel Syndrome, Non-alcoholic Fatty Liver Disease | 4 |
| St. Jude Clinical Research | Dermatitis Atopic, Bipolar I Disorder, Atopic Dermatitis | 4 |
| AMR Clinical | Asthma, Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity | 3 |
| Sylvester Comprehensive Cancer Center- Doral | Multiple Myeloma, Breast Cancer, Breast Neoplasms | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| D&H Doral Research Center | Alopecia Areata, Diabetic Kidney Disease (DKD) | 2 |
| Science Connections LLC | Agitation Associated With Alzheimer's Dementia, Psychosis Associated With Alzheimer's Disease | 2 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| ADARx Clinical Site | C3G, Complement-mediated Kidney Disease, IC-MPGN | 1 |
| AMR-Miami | Diabetic Peripheral Neuropathic Pain | 1 |
| Bausch | Psoriasis | 1 |
| Betancourt Research Services | Psychosis Associated With Alzheimer's Disease | 1 |
| BioResearch Partner ? Jackson West | Primary IgA Nephropathy | 1 |
| Bioresearch Partner | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
| D&H Doral Research Center LLC | Alopecia, Areata Alopecia, Hair Diseases | 1 |
| D&H Doral Research Center-Doral | Bipolar I Disorder, Depression | 1 |
| DM Clinical Research - MIA | HOMA-IR, Mobility Disability, Obesity & Overweight | 1 |
| Dr. Falk Investigational Site | Eosinophilic Esophagitis | 1 |
| Family Research and Healthcare Center Inc. | Lipoprotein Disorder | 1 |
| First Excellent Research Group | Alzheimer's Disease Psychosis | 1 |
| I.V.A.M. Clinical & Investigational Center, LLC | Ulcerative Colitis, Ulcerative Colitis Chronic | 1 |
| ICR Sites East | Gout | 1 |
Active & Upcoming Studies in Doral (2026)
Recruiting trials in Doral grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (22 active studies)
- An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers · Phase 1 · Pfizer
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (9 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin · Phase 3 · AstraZeneca
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss · Phase 2 · Veru Inc.
Cardiovascular (4 active studies)
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension · Phase 2 · Vanda Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (3 active studies)
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
- NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia · Phase 3 · Neurocrine Biosciences
Vaccines (1 active study)
Neurology & pain (1 active study)
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Common conditions studied in Doral
- Psychosis Associated With Alzheimer's Disease (4 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Atopic Dermatitis (2 active studies)
- Bipolar I Disorder (2 active studies)
- Breast Cancer (2 active studies)
- Dermatitis Atopic (2 active studies)
Leading research sponsors in Doral
- NRG Oncology
- National Cancer Institute (NCI)
- Pfizer
- Eli Lilly and Company
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Doral?
There are approximately 87 recruiting clinical trials in Doral, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Doral pay participants?
Most recruiting trials in Doral compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Doral?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Doral?
The most common conditions under active study in Doral include Psychosis Associated With Alzheimer's Disease (4), Anatomic Stage IV Breast Cancer AJCC v8 (2), Atopic Dermatitis (2), Bipolar I Disorder (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Doral?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Doral on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Doral?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Doral?
Recruiting research sites in Doral include UM Sylvester Comprehensive Cancer Center at Doral, Dolphin Medical Research, Universal Axon Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Doral right now?
The largest active categories in Doral are Cancer & tumors (22), Diabetes & metabolic (9), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.